PROTALIX BIOTHERAPEUTICS INC

Ticker: PLX CUSIP: 74365A309 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 262,809 Value ($000) $473 Avg Close $2.04 Range $1.60 - $2.66
Q3 2025
Shares 150,829 Value ($000) $335 Avg Close $1.63 Range $1.36 - $2.26
Q2 2025
Shares 102,178 Value ($000) $151 Avg Close $2.05 Range $1.32 - $3.10
Q1 2025
Shares 289,461 Value ($000) $741 Avg Close $2.39 Range $1.86 - $2.76
Q4 2024
Shares 49,710 Value ($000) $93 Avg Close $1.41 Range $0.99 - $1.96
Q3 2024
Shares 50,241 Value ($000) $51 Avg Close $1.05 Range $0.82 - $1.22
Q2 2024
Shares 461,958 Value ($000) $540 Avg Close $1.18 Range $1.03 - $1.37
Q1 2024
Shares 92,424 Value ($000) $116 Avg Close $1.49 Range $1.21 - $1.85
Q4 2023
Shares 104,476 Value ($000) $186 Avg Close $1.56 Range $1.21 - $1.90
Q3 2023
Shares 107,795 Value ($000) $179 Avg Close $1.79 Range $1.43 - $2.09
Q2 2023
Shares 50,194 Value ($000) $100 Avg Close $2.38 Range $1.90 - $3.55